Search results
Sanofi-GSK's Next-Gen COVID-19 Booster Shows Potential Against Variants Of Concern
Benzinga via Yahoo Finance· 2 years agoSanofi SA (NASDAQ: SNY) said the next-gen COVID-19 vaccine candidate it has developed with GSK Plc...
Sanofi's $3B Acquisition Of Provention Bio Hits Regulatory Roadblock: FTC Requests More Information
Benzinga via Yahoo Finance· 1 year agoSanofi SA (NASDAQ: SNY) withdrew and refiled the Premerger Notification and Report Form under the...
Sanofi Expects Moderate 2023 Profit Growth On Dupixent Demand, But Dampened By Aubagio Generics...
Benzinga via Yahoo Finance· 1 year agoSanofi SA (NASDAQ: SNY) forecasts 2023 adjusted earnings per share to grow by a "low single-digit"...
Sanofi Forecasts Foreign Exchange, Record Flu Vaccine Sales To Boost Q4 Earnings
Benzinga via Yahoo Finance· 1 year agoAs Sanofi SA (NASDAQ: SNY) schedules to report Q4 FY22 earnings early next month, it expects a...
Sanofi-GSK's Beta-Containing COVID-19 Vaccine Shows Efficacy Against Omicron
Benzinga via Yahoo Finance· 2 years agoSanofi SA (NASDAQ: SNY) and GSK plc (NYSE: GSK) have announced positive data from their vaccine...
Sanofi Opts To Terminate Rare Disease Program With Regulus Therapeutics
Benzinga via Yahoo Finance· 1 year agoSanofi SA (NASDAQ: SNY) elected to terminate its second amended and restated collaboration and...
Sanofi Lowers Out-Of-Pocket Insulin Cost For Uninsured Patients
Benzinga via Yahoo Finance· 2 years agoSanofi SA (NASDAQ: SNY) said that uninsured diabetes patients in the U.S. will pay no more than $35...
Sanofi (SNY) Dupixent Gets CHMP Nod to Eosinophilic Esophagitis
Zacks via Yahoo Finance· 1 year agoThe CHMP recommends approval of Sanofi (SNY) and partner Regeneron's Dupixent for the treatment of...
Why Regeneron Pharmaceuticals And Sanofi Shares Are Trading Higher Today
Benzinga via Yahoo Finance· 1 year agoSanofi-Regeneron stocks are trading higher today after their blockbuster drug aced the pivotal COPD...
Sanofi Ends Development Of Breast Cancer Drug Amcenestrant After Trial Failure
Benzinga via Yahoo Finance· 2 years agoSanofi SA (NASDAQ: SNY) said it would stop further work on breast cancer drug amcenestrant, putting...